Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
A novel cAMP-biased Mechanism Ecnoglutide injection represents the world's first approved long-acting cAMP-biased glucagon-like peptide-1 (GLP-1) receptor agonist
Do you feel energized during workouts
Canadian Employer Plans Covering GLP-1s for Weight Loss Have Nearly Doubled Data from the International Foundation of Employee Benefit Plans (IFEBP) 2025 Pulse Survey shows a significant shift in Canadian employer attitudes toward GLP-1 coverage: 31% of employer plans now cover GLP-1s for weight loss (up from 17% in 2024) 56% cover for diabetes only (down from 66% in 2024) 20% of diabetes-only plans are considering adding obesity coverage Provincial public drug plans still cover semaglutide only for type 2 diabetes not for weight loss
Every clinic should make it this easy
Key Features: Custom-fit layout: Holds 10 3ml vials Hard shell exterior: Durable, impact-resistant protection Secure closure: Keeps contents safely contained Precision interior insert: Reduces movement and vibration Mid-size & portable: Balanced capacity for daily use or travel Designed for clean organization and reliable protection in any research environment
